Maurin, Wilfredo G.
HRN: 13-81-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/13/2025
10/20/2025
IV
4.5g LD Then 2.25g
Q6
SEPTIC SHOCK
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes